Literature DB >> 24968735

Down-regulation of miR-144 promotes thyroid cancer cell invasion by targeting ZEB1 and ZEB2.

Hongyu Guan1, Weiwei Liang, Zhiwei Xie, Hai Li, Juan Liu, Liehua Liu, Lingling Xiu, Yanbing Li.   

Abstract

Thyroid cancer is the most common endocrine malignancy, and its incidence has increased rapidly worldwide. The molecular mechanisms underlying thyroid cancer tumorigenesis still need to be further investigated. MicroRNAs (miRNAs), short RNA molecules of approximately 22 nucleotides in length, play crucial roles in tumorigenesis. In the present study, we found that the expression of miR-144 was significantly down-regulated in thyroid cancer as compared with that in normal thyroid tissues, suggesting that miR-144 may be involved in thyroid cancer tumorigenesis. Moreover, our results showed that restoration of miR-144 in K1 and WRO thyroid cancer cells could suppress the invasion and migration capability of these cells. We also demonstrated that miR-144 suppressed the expression of ZEB1 and ZEB2, two E-cadherin suppressors, by directly binding to their 3'-untranslated regions. Furthermore, restoration of ZEB1 or ZEB2 partially rescued the miR-144-induced inhibition of cell invasion. These data suggest miR-144 function as a tumor suppressor in thyroid cancer.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24968735     DOI: 10.1007/s12020-014-0326-7

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  40 in total

1.  Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets.

Authors:  Benjamin P Lewis; Christopher B Burge; David P Bartel
Journal:  Cell       Date:  2005-01-14       Impact factor: 41.582

2.  The role of microRNA genes in papillary thyroid carcinoma.

Authors:  Huiling He; Krystian Jazdzewski; Wei Li; Sandya Liyanarachchi; Rebecca Nagy; Stefano Volinia; George A Calin; Chang-Gong Liu; Kaarle Franssila; Saul Suster; Richard T Kloos; Carlo M Croce; Albert de la Chapelle
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-19       Impact factor: 11.205

3.  Induction of ZEB proteins by inactivation of RB protein is key determinant of mesenchymal phenotype of breast cancer.

Authors:  Yoshimi Arima; Hidemi Hayashi; Mikako Sasaki; Mari Hosonaga; Takaaki M Goto; Tatsuyuki Chiyoda; Shinji Kuninaka; Tatsuhiro Shibata; Hirokazu Ohata; Hitoshi Nakagama; Yoichi Taya; Hideyuki Saya
Journal:  J Biol Chem       Date:  2012-01-19       Impact factor: 5.157

4.  A transient, EMT-linked loss of basement membranes indicates metastasis and poor survival in colorectal cancer.

Authors:  Simone Spaderna; Otto Schmalhofer; Falk Hlubek; Geert Berx; Andreas Eger; Susanne Merkel; Andreas Jung; Thomas Kirchner; Thomas Brabletz
Journal:  Gastroenterology       Date:  2006-09       Impact factor: 22.682

Review 5.  Thyroid carcinoma.

Authors:  Steven I Sherman
Journal:  Lancet       Date:  2003-02-08       Impact factor: 79.321

6.  The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs.

Authors:  Ulrich Wellner; Jörg Schubert; Ulrike C Burk; Otto Schmalhofer; Feng Zhu; Annika Sonntag; Bettina Waldvogel; Corinne Vannier; Douglas Darling; Axel zur Hausen; Valerie G Brunton; Jennifer Morton; Owen Sansom; Julia Schüler; Marc P Stemmler; Christoph Herzberger; Ulrich Hopt; Tobias Keck; Simone Brabletz; Thomas Brabletz
Journal:  Nat Cell Biol       Date:  2009-11-22       Impact factor: 28.824

7.  Expression of the ZEB1 (deltaEF1) transcription factor in human: additional insights.

Authors:  Elaine M Hurt; Jessica N Saykally; Bynthia M Anose; Kimberly R Kalli; Michel M Sanders
Journal:  Mol Cell Biochem       Date:  2008-07-12       Impact factor: 3.396

8.  CDKN2A, NF2, and JUN are dysregulated among other genes by miRNAs in malignant mesothelioma -A miRNA microarray analysis.

Authors:  Mohamed Guled; Leo Lahti; Pamela M Lindholm; Kaisa Salmenkivi; Izhar Bagwan; Andrew G Nicholson; Sakari Knuutila
Journal:  Genes Chromosomes Cancer       Date:  2009-07       Impact factor: 5.006

9.  Epigallocatechin gallate inhibits growth and epithelial-to-mesenchymal transition in human thyroid carcinoma cell lines.

Authors:  Francesca De Amicis; Anna Perri; Donatella Vizza; Alessandra Russo; Maria Luisa Panno; Daniela Bonofiglio; Cinzia Giordano; Loredana Mauro; Saveria Aquila; Donatella Tramontano; Sebastiano Andò
Journal:  J Cell Physiol       Date:  2013-10       Impact factor: 6.384

10.  mRNA expression in papillary and anaplastic thyroid carcinoma: molecular anatomy of a killing switch.

Authors:  Aline Hébrant; Geneviève Dom; Michael Dewaele; Guy Andry; Christophe Trésallet; Emmanuelle Leteurtre; Jacques E Dumont; Carine Maenhaut
Journal:  PLoS One       Date:  2012-10-24       Impact factor: 3.240

View more
  45 in total

1.  miR-29a suppresses growth and metastasis in papillary thyroid carcinoma by targeting AKT3.

Authors:  Rui Li; Jia Liu; Qun Li; Guang Chen; Xiaofang Yu
Journal:  Tumour Biol       Date:  2015-10-19

2.  miR-144 suppresses cell proliferation and invasion in gastric cancer through downregulation of activating enhancer-binding protein 4.

Authors:  Faheim Mushtaq; Jinping Zhang; Jiansheng Li
Journal:  Oncol Lett       Date:  2019-04-04       Impact factor: 2.967

3.  MicroRNA-144 inhibits the proliferation, apoptosis, invasion, and migration of osteosarcoma cell line F5M2.

Authors:  Shao-Qian Cui; Huan Wang
Journal:  Tumour Biol       Date:  2015-04-09

Review 4.  Emerging strategies for managing differentiated thyroid cancers refractory to radioiodine.

Authors:  Stefania Bulotta; Marilena Celano; Giuseppe Costante; Diego Russo
Journal:  Endocrine       Date:  2015-12-21       Impact factor: 3.633

5.  Effects of miR-144 on the sensitivity of human anaplastic thyroid carcinoma cells to cisplatin by autophagy regulation.

Authors:  Jing Liu; Liguo Feng; Haitao Zhang; Jin Zhang; Yanyan Zhang; Shujing Li; Long Qin; Ziyao Yang; Jianxia Xiong
Journal:  Cancer Biol Ther       Date:  2018-03-26       Impact factor: 4.742

Review 6.  Epithelial-to-mesenchymal transition in thyroid cancer: a comprehensive review.

Authors:  Heewa Shakib; Sadegh Rajabi; Mohammad Hossien Dehghan; Farideh Jalali Mashayekhi; Nahid Safari-Alighiarloo; Mehdi Hedayati
Journal:  Endocrine       Date:  2019-08-04       Impact factor: 3.633

7.  Comprehensive gene and microRNA expression profiling reveals a role for miRNAs in the oncogenic roles of SphK1 in papillary thyroid cancer.

Authors:  Weiwei Liang; Zhiwei Xie; Weiling Cui; Yan Guo; Lijuan Xu; Jueheng Wu; Hongyu Guan
Journal:  J Cancer Res Clin Oncol       Date:  2016-12-10       Impact factor: 4.553

8.  Regulation of activating protein-4-associated metastases of non-small cell lung cancer cells by miR-144.

Authors:  Feng Gao; Tao Wang; Zefeng Zhang; Rui Wang; Yang Guo; Junfeng Liu
Journal:  Tumour Biol       Date:  2015-08-08

9.  miR-154 inhibits migration and invasion of human non-small cell lung cancer by targeting ZEB2.

Authors:  Xingyu Lin; Zhiguang Yang; Peng Zhang; Yunpeng Liu; Guoguang Shao
Journal:  Oncol Lett       Date:  2016-05-16       Impact factor: 2.967

10.  miR-144 suppresses the growth and metastasis of laryngeal squamous cell carcinoma by targeting IRS1.

Authors:  Xin Wu; Chang-Lei Cui; Wei-Lun Chen; Zhong-Ying Fu; Xiang-Yan Cui; Xu Gong
Journal:  Am J Transl Res       Date:  2016-01-15       Impact factor: 4.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.